These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 6165428)

  • 41. Human leukocyte interferon: relationship between molecular structure and species specificity.
    Thang MN; Thang DC; Chelbi-Alix MK; Robert-Galliot B; Commoy-Chevalier MJ; Chany C
    Proc Natl Acad Sci U S A; 1979 Aug; 76(8):3717-21. PubMed ID: 291036
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of cloned interferon alpha 2 in normal volunteers: febrile reactions and changes in circulating corticosteroids and trace metals.
    Scott GM; Ward RJ; Wright DJ; Robinson JA; Onwubalili JK; Gauci CL
    Antimicrob Agents Chemother; 1983 Apr; 23(4):589-92. PubMed ID: 6859837
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Partial purification and characterization of bovine fibroblast interferon.
    Allen GK; Grothaus GD; Rosenquist BD
    Am J Vet Res; 1988 Jun; 49(6):758-61. PubMed ID: 2456705
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Purification of mouse cell interferon induced by isotopically labelled double-stranded f2 phage RNA.
    Táborský I; Doskocil J; Stancek D
    J Hyg Epidemiol Microbiol Immunol; 1977; 21(3):261-70. PubMed ID: 564366
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Analysis and purification of human lymphoblastoid (Namalwa) interferon using a monoclonal antibody.
    Allen G; Fantes KH; Burke DC; Morser J
    J Gen Virol; 1982 Nov; 63 (Pt 1)():207-12. PubMed ID: 7175502
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Biological similarities of rat fibroblast interferon to human and mouse alpha interferons.
    Davis CT; Rusckowski M; Murasko DM
    J Gen Virol; 1985 Sep; 66 ( Pt 9)():1961-8. PubMed ID: 2411850
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Method of increasing the activity of a preparation of human cadaver leukocyte interferon].
    Parfenov VV; Zubanova NA; Mekhedov LN; Pokidysheva LN; Kuznetsov VP
    Vopr Virusol; 1980; (3):294-7. PubMed ID: 6159731
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The kinetics of human interferon clearance in gibbons.
    Skreko F; Zajac I; Bahnsen HP; Haff RF; Cantell K
    Proc Soc Exp Biol Med; 1973 Mar; 142(3):946-7. PubMed ID: 4692028
    [No Abstract]   [Full Text] [Related]  

  • 49. Purification of interferon by adsorption chromatography on controlled pore glass.
    Edy VG; Braude IA; De Clercq E; Billiau A; De Somer P
    J Gen Virol; 1976 Dec; 33(3):517-21. PubMed ID: 1036458
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Production of human leukocyte interferon for clinical use under immunoelectrophoretic control.
    Fuchsberger N; Borecký L
    Acta Biol Med Ger; 1979; 38(5-6):795-800. PubMed ID: 230675
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Physico-chemical characterization and partial purification of mouse immune interferon.
    Wietzerbin J; Stefanos S; Lucero M; Falcoff E; O'Malley JA; Sulkowski E
    J Gen Virol; 1979 Sep; 44(3):773-81. PubMed ID: 43358
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Clinical trials of recombinant gamma-interferon. Circulating interferon and the 2,5-oligoadenylate synthetase activity after intramuscular and inhalation administrations].
    Sokolova TM; Lopatina OA; Nosik NN; Cheshik SG
    Biull Eksp Biol Med; 1993 Jun; 115(6):633-4. PubMed ID: 7690616
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Tolerability of pure fibroblast interferon in man.
    Billiau A; Heine JW; Van Damme J; Heremans H; De Somer P
    Ann N Y Acad Sci; 1980; 350():374-5. PubMed ID: 6165288
    [No Abstract]   [Full Text] [Related]  

  • 54. Production and preparation of human fibroblast interferon for clinical trials.
    Leong SS; Horoszewicz JS
    Methods Enzymol; 1981; 78(Pt A):87-101. PubMed ID: 6173652
    [No Abstract]   [Full Text] [Related]  

  • 55. Lethality of interferon preparations for newborn mice.
    Gresser I; Tovey MG; Maury C; Chouroulinkov I
    Nature; 1975 Nov; 258(5530):76-8. PubMed ID: 1186883
    [No Abstract]   [Full Text] [Related]  

  • 56. Toxicity of interferon.
    Fumarola D
    Br Med J (Clin Res Ed); 1981 Nov; 283(6304):1468-9. PubMed ID: 6172179
    [No Abstract]   [Full Text] [Related]  

  • 57. Toxic effects of interferon.
    Oldham RR
    Science; 1983 Feb; 219(4587):902. PubMed ID: 6186027
    [No Abstract]   [Full Text] [Related]  

  • 58. Toxicity of interferon.
    Fumarola D
    Br Med J (Clin Res Ed); 1981 Jul; 283(6285):235. PubMed ID: 6167309
    [No Abstract]   [Full Text] [Related]  

  • 59. Targeting of Immune Cells by Dual TLR2/7 Ligands Suppresses Features of Allergic Th2 Immune Responses in Mice.
    Laiño J; Wangorsch A; Blanco F; Wolfheimer S; Krause M; Flaczyk A; Möller TM; Tsai M; Galli S; Vieths S; Toda M; Scheurer S; Schülke S
    J Immunol Res; 2017; 2017():7983217. PubMed ID: 29204451
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Risks and benefits of interferon-alpha in the treatment of hepatitis.
    Pardo M; Marriott E; Moliner MC; Quiroga JA; Carreño V
    Drug Saf; 1995 Nov; 13(5):304-16. PubMed ID: 8785018
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.